Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Beyond the BBB

Financiado

Nerve Growth Factor Delivery into the Brain – focus on therapeutic potential in...

Nerve Growth Factor Delivery into the Brain – focus on therapeutic potential in Alzheimer’s disease and In Vivo Evaluation via PET Alzheimer’s disease (AD) is a neurodegenerative disease affecting the aged population and is projected to increase 3-fold in the next 30 years. Treatment options in AD are limited due to complex pathological processes and the bloo... ver más

31/03/2025

UCPH

215K€

Presupuesto del proyecto: 215K€

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-03-02

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022 ExpectedOutcome:

I+D

Cerrada hace 2 años

0% 100% 100%

1 Participantes

UCPH

214.93K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

DeliChoP Drug DELIvery to the brain via CHOroid Plexus targeting 2M€ Cerrado

SAF2017-91909-EXP CONTROL DIFERENCIAL DEL TRANSPORTE DE VEHICULOS TERAPEUTICOS... 54K€ Cerrado

OBGate Creating an orthogonal gate to the brain 1M€ Cerrado

SAF2013-42347-R FACTORES NEUROTROFICOS NANOENCAPSULADOS Y TERAPIA GENICA PAR... 242K€ Cerrado

EIN2019-103356 PORTADOR POLIPEPTIDICO INTRANASAL PARA EL TRATAMIENTO DE PAT... 10K€ Cerrado

PID2019-108806RB-I00 APROXIMACION SINERGICA AL DESARROLLO DE TERAPIAS PARA TUMORE... 242K€ Cerrado

Duración del proyecto: 24 meses Fecha Inicio: 2023-03-02
Fecha Fin: 2025-03-31

Líder del proyecto

KOBENHAVNS UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 215K€

Descripción del proyecto Alzheimer’s disease (AD) is a neurodegenerative disease affecting the aged population and is projected to increase 3-fold in the next 30 years. Treatment options in AD are limited due to complex pathological processes and the blood-brain barrier (BBB), which restrict entry molecules into the brain. A finding in AD is the loss of cholinergic neurons. Tropomyosin receptor kinase A (TrkA) and its substrate, the nerve growth factor (NGF), are involved in neuronal survival and have been evaluated in small clinical trials as a therapeutic intervention in AD. Advances in BBB shuttling methods, in which antibodies and enzymes can be transported over the BBB, make NGF a possible treatment option in AD. Within this proposal, I will develop novel methods for the delivery of NGF into the brain. Two different approaches for BBB delivery of NGF will improve the success rate. In one approach, NGF will be delivered into the brain by transferrin receptor (TfR)-mediated transcytosis. NGF will be chemically conjugated to a TfR binding antibody using a linker that selectively and quantifiably can release NGF in its native form in the brain, ensuring retained biological activity. An alternative approach, BBB will be opened with focused ultrasounds allowing passage of NGF into the brain. Positron emission tomography occupancy studies with [18F]TRACK, a TrkA selective tracer, will be used to evaluate in vivo binding of NGF to TrkA. The above-described BBB transport methods for NGF will be evaluated in long-term therapeutic study using 5xFAD mice. Pharmacodynamic readouts will be changes in brain amyloid-beta levels, neuroinflammation parameters and improved memory and cognitive functions. In this project, I will expand my knowledge in BBB delivery of macromolecules, learn new radiolabeling techniques from a world-leading radiochemist, and novel develop the necessary skills to take my career to the next level.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores